ArticleCardiovascular diabetology2004

Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study).

Carlos A Aguilar-Salinas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.